Anzeige
++++++ Nach 600 % mit Moderna!: Cardiol Therapeutics vor Neubewertung! Analysten sehen massives Kurspotential ++++++
Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
Original-Research

EBRO MOTORS GROUP EV SA (von NuWays AG): BUY 12.10.2026, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Ebro EV Motors 9,825 EUR +1,03 % Quotrix Düsseldorf
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.

Original-Research: EBRO MOTORS GROUP EV SA - from NuWays AG



12.10.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.



---------------------------------------------------------------------------



Classification of NuWays AG to EBRO MOTORS GROUP EV SA



     Company Name:                EBRO MOTORS GROUP EV SA
     ISIN:                        ES0105725008



     Reason for the research:     Initiation
     Recommendation:              BUY
     Target price:                EUR 14.50
     Target price on sight of:    12 months
     Last rating change:
     Analyst:                     Jorge Gonzalez



A Spanish automotive revival gaining scale; INITIATE WITH BUY



EBRO Motors Group EV SA (EBRO) is an emerging Spanish automaker combining
the revival of a historic automotive brand, the reindustrialisation of
Barcelona's Zona Franca and a joint venture with Chinese automaker Chery.
This provides a differentiated route to becoming an automotive OEM: Chery
contributes established vehicle platforms, electrified powertrains and
procurement scale, while EBRO brings Spanish brand heritage, local
manufacturing and a growing distribution network. Built around Nissan's
former Barcelona plant, the partnership gives EBRO access to technology and
industrial infrastructure that would be costly and time-consuming to develop
independently.



An initial Spanish market share of c. 2.2% in 9M'26 demonstrates the appeal
of this proposition. Brand heritage, sustained marketing investment and the
Barcelona reindustrialisation story support consumer recognition and trust,
while competitive pricing, attractive equipment and modern powertrains
underpin the product offering. This penetration has been achieved with a
portfolio limited to SUVs and sales concentrated in private buyers and
rent-a-car customers. Corporate fleets and long-term leasing therefore
represent a sizeable opportunity: the corporate channel accounted for 36.4%
of Spanish passenger-car registrations in 2025.



Portfolio and distribution expansion should sustain growth beyond the
initial launch phase. We forecast a c. 50bps increase in Spanish market
share to c. 2.7% by 2030e, supported by an urban BEV launch in 2027, further
dealership openings and greater corporate-channel penetration. Gradual
international expansion provides an additional growth engine, contributing
c. 10k annual vehicle sales and taking total EBRO-branded sales to c. 42k
vehicles by 2030.



Chery production allocations could unlock the next stage of operating
leverage. We see confirmation of the first additional assembly volumes as a
key potential near-term catalyst. These would improve utilisation of
Barcelona's substantial industrial footprint, spread fixed costs across a
larger production base and accelerate margin expansion. The plant also
offers Chery a strategic platform for strengthening its European industrial
presence, progressively increasing localisation and potentially mitigating
exposure to EU trade barriers. Our forecasts assume combined EBRO and Chery
production reaches c. 90k vehicles by 2030.



We initiate coverage with BUY and a DCF-based PT of EUR 14.50. Our investment
case rests on continued commercial growth and improving factory utilisation
driving profitability. The valuation assumes a terminal EBIT margin of 9.9%,
perpetual growth of 2% and a WACC of c. 10%, and incorporates the additional
equity funding and associated dilution assumed to support the industrial
expansion.



You can download the research here:
https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&u=aaf40b7c226a098aa347e92e82ea994e
For additional information visit our website:
https://www.nuways-ag.com/research



Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++



---------------------------------------------------------------------------



The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
View original content:
https://eqs-news.com/?origin_id=2c9ff409-c603-11f1-9d22-0a083a71a9ab&lang=en



---------------------------------------------------------------------------



2413800 12.10.2026 CET/CEST




Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer